3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
2
Recruiting
2
Terminated
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
26
Lymphoma, Large B-Cell, Diffuse
17
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Lymphoma
6
Neoplasms
5
Lymphoma, Non-Hodgkin
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Leukemia, Biphenotypic, Acute
3
Recurrence
2
Prostatic Neoplasms, Castration-Resistant
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Ovarian Neoplasms
2
Myasthenia Gravis
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Diseases
1
Interventions
fludarabine
6
efgartigimod alfa
6
Cyclophosphamide
6
ravulizumab
4
zilucoplan
2
telitacicept
2
rozanolixizumab
2
Prednisone
2
remibrutinib
1
iptacopan
1
inebilizumab
1
bu-zhong-yi-qi-tang
1
Walk Test
1
Tacrolimus
1
Steroids
1
Rituximab
1
Pyridostigmine Bromide
1
Prednisolone
1
Mycophenolic Acid
1
Diagnostic Self Evaluation
1
Cognitive Behavioral Therapy
1
Cladribine
1
Biomarkers
1
Azathioprine
1
Alleles
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Myasthenia Gravis
×
Prednisone
×
Clear all
NCT07221838
2026-04-09
OCTAGON
Alexion Pharmaceuticals, Inc.
Phase 4
Recruiting
75 enrolled
NCT04182984
2026-01-30
TREAT-OMG
Tang-Du Hospital
Recruiting
200 enrolled